Smartwatch May Be Able to Passively Detect Atrial Fibrillation

Share this content:
Smartwatch May Be Able to Passively Detect Atrial Fibrillation
Smartwatch May Be Able to Passively Detect Atrial Fibrillation

FRIDAY, March 23, 2018 (HealthDay News) -- A smartwatch coupled with a machine learning algorithm is able to accurately detect atrial fibrillation (AF), with some loss of specificity and sensitivity compared to criterion-standard electrocardiography (ECG), according to a study published online March 21 in JAMA Cardiology.

Geoffrey H. Tison, M.D., M.P.H., from the University of California, San Francisco, and colleagues used heart rate and step count data obtained from 9,750 participants enrolled in the Health eHeart Study. Data were used to develop an algorithm capable of detecting AF on a smartwatch.

The researchers trained the algorithm using 139 million heart rate measurements. The deep neural network exhibited a C statistic of 0.97 (P < 0.001) to detect AF against the reference standard of AF diagnosed with a 12-lead ECG. In the external validation cohort of 51 patients undergoing cardioversion, the algorithm's sensitivity and specificity were 98.0 and 90.2 percent, respectively. Using self-report of persistent AF in ambulatory participants for exploratory analysis, the C statistic was 0.72, sensitivity was 67.7 percent, and specificity was 67.6 percent.

"This proof-of-concept study found that smartwatch photoplethysmography coupled with a deep neural network can passively detect AF but with some loss of sensitivity and specificity against a criterion-standard ECG," the authors write.

Several authors disclosed financial ties to medical device companies, including Cardiogram, which partially funded the study.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »